Alopecia areata (AA) is a non-scarring, autoimmune, inflammatory, relapsing hair loss affecting the scalp and/or body. In acute-phase AA, CD4+ and CD8+ T cells infiltrated in the juxta-follicular area. In chronic-phase AACD8+ T cells dominated the infiltrate around hair bulbs which contributes to the prolonged state of hair loss. Treatments include mainly corticosteroids, topical irritants, minoxidil, cytotoxic drugs and biologicals. This review highlights mainly the pathomechanism and pathology, classifications and associated diseases with regard to their importance for current and future treatment
The treatment of hair loss diseases is sometimes difficult because of insufficient efficacy and limi...
Over the past decade, basic research has established alopecia areata as a T cell–mediated autoimmune...
noAlopecia areata is an immunologically mediated disease characterized by extreme variability not on...
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, inc...
It is the aim of this article to review and appraise available data on treatments for alopecia areat...
Over the past decade, basic research has established alopecia areata as a T cell–mediated autoimmune...
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and pre...
Abstract. Alopecia areata is nonscarring telogenic alopecia of autoimmune etiology. It is estimated ...
AbstractAlopecia areata (AA) is a nonscarring, autoimmune hair loss on the scalp, and/or body. Etiol...
Alopecia areata (AA) severity varies from a single small patch to complete loss of scalp hair, body ...
Alopecia Areata (AA) is a common non-scarring alopecia that usually presents as well circumscribed p...
Selection of a therapy for a patient with alopecia areata (AA) is frequently based on the age of the...
AbstractThe treatment of hair loss diseases is sometimes difficult because of insufficient efficacy ...
Alopecia areata (AA) is a common autoimmune nonscarring alopecia. AA presents heterogeneously and is...
The treatment goal in alopecia areata is induction of hair regrowth and halting the progression of t...
The treatment of hair loss diseases is sometimes difficult because of insufficient efficacy and limi...
Over the past decade, basic research has established alopecia areata as a T cell–mediated autoimmune...
noAlopecia areata is an immunologically mediated disease characterized by extreme variability not on...
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, inc...
It is the aim of this article to review and appraise available data on treatments for alopecia areat...
Over the past decade, basic research has established alopecia areata as a T cell–mediated autoimmune...
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and pre...
Abstract. Alopecia areata is nonscarring telogenic alopecia of autoimmune etiology. It is estimated ...
AbstractAlopecia areata (AA) is a nonscarring, autoimmune hair loss on the scalp, and/or body. Etiol...
Alopecia areata (AA) severity varies from a single small patch to complete loss of scalp hair, body ...
Alopecia Areata (AA) is a common non-scarring alopecia that usually presents as well circumscribed p...
Selection of a therapy for a patient with alopecia areata (AA) is frequently based on the age of the...
AbstractThe treatment of hair loss diseases is sometimes difficult because of insufficient efficacy ...
Alopecia areata (AA) is a common autoimmune nonscarring alopecia. AA presents heterogeneously and is...
The treatment goal in alopecia areata is induction of hair regrowth and halting the progression of t...
The treatment of hair loss diseases is sometimes difficult because of insufficient efficacy and limi...
Over the past decade, basic research has established alopecia areata as a T cell–mediated autoimmune...
noAlopecia areata is an immunologically mediated disease characterized by extreme variability not on...